Abstract:Pluripotency is established through genome-wide reprogramming during mammalian pre-implantation development, resulting in the formation of the naive epiblast. Reprogramming involves both the resetting of epigenetic marks and the activation of pluripotent-cell-specific genes such as Nanog and Oct4 (also known as Pou5f1). The tight regulation of these genes is crucial for reprogramming, but the mechanisms that regulate their expression in vivo have not been uncovered. Here we show that Nanog--but not Oct4--is monoallelically expressed in early pre-implantation embryos. Nanog then undergoes a progressive switch to biallelic expression during the transition towards ground-state pluripotency in the naive epiblast of the late blastocyst. Embryonic stem (ES) cells grown in leukaemia inhibitory factor (LIF) and serum express Nanog mainly monoallelically and show asynchronous replication of the Nanog locus, a feature of monoallelically expressed genes, but ES cells activate both alleles when cultured under 2i conditions, which mimic the pluripotent ground state in vitro. Live-cell imaging with reporter ES cells confirmed the allelic expression of Nanog and revealed allelic switching. The allelic expression of Nanog is regulated through the fibroblast growth factor-extracellular signal-regulated kinase signalling pathway, and it is accompanied by chromatin changes at the proximal promoter but occurs independently of DNA methylation. Nanog-heterozygous blastocysts have fewer inner-cell-mass derivatives and delayed primitive endoderm formation, indicating a role for the biallelic expression of Nanog in the timely maturation of the inner cell mass into a fully reprogrammed pluripotent epiblast. We suggest that the tight regulation of Nanog dose at the chromosome level is necessary for the acquisition of ground-state pluripotency during development. Our data highlight an unexpected role for allelic expression in controlling the dose of pluripotency factors in vivo, adding an extra level to the regulation of reprogramming.

Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human

Pluripotential competence of cells associated with Nanog activity

Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells

Transcriptional Regulation of Nanog by OCT4 and SOX2

Multiple phases in regulation of Nanog expression during pre-implantation development

Nanog safeguards pluripotency and mediates germline development

A Heterogeneous Expression Pattern for Nanog in Embryonic Stem Cells

Control of ground-state pluripotency by allelic regulation of Nanog

NANOG expression in parthenogenetic porcine blastocysts is required for intact lineage specification and pluripotency

Overexpression Nanog activates pluripotent genes in porcine fetal fibroblasts and nuclear transfer embryos.

The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells

Nanos2 Promotes Differentiation of Chicken (gallus Gallus) Embryonic Stem Cells to Male Germ Cells

Concise Review: Pursuing Self-Renewal and Pluripotency with the Stem Cell Factor Nanog

NANOG initiates epiblast fate through the coordination of pluripotency genes expression

Nanog regulates molecules involved in stemness and cell cycle-signaling pathway for maintenance of pluripotency of P19 embryonal carcinoma stem cells

Pluripotency Activity of Nanog Requires Biochemical Stabilization by Variant Histone Protein H2a.Z

The Pluripotency Factor Nanog Promotes Breast Cancer Tumorigenesis and Metastasis

Nanog in human tumors and stem cells

Effect of NANOG Overexpression on Porcine Embryonic Development and Pluripotent Embryonic Stem Cell Formation in Vitro

Nanog and transcriptional networks in embryonic stem cell pluripotency

The pluripotency factor NANOG controls primitive hematopoiesis and directly regulates Tal1